EU project for the development of Crimean-Congo Haemorrhagic Fever virus (CCHFV) vaccines starts

On 25 and 26 January the CCHFVaccine kick-off meeting took place at the Paul-Ehrlich-Institut. CCHFVaccine is a multinational and interdisciplinary research project. This consortium will investigate model vaccines against Crimean-Congo haemorrhagic fever for the protection of humans and animals. The Paul-Ehrlich-Institut and the Friedrich-Loeffler-Institut are among the 14 partners involved and will support the project with its regulatory expertise as well as Biosafety Level 4 experimental capacity.